Application of glioma prognostic marker Circ9:135881633|135883078

A glioma and prognosis technology, applied in the application of reagents in the preparation of glioma prognostic preparations, and the application field of circRNA markers, can solve the problems that the survival rate of glioma patients has not been significantly improved, and the survival rate is not optimistic.
CN107586844AInactive Publication Date: 2018-01-16XIANGYA HOSPITAL CENT SOUTH UNIV

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
XIANGYA HOSPITAL CENT SOUTH UNIV
Publication Date
2018-01-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of biology and discloses application of a glioma prognostic marker Circ9:135881633|135883078, in particular to application of a reagent for detecting the expression quantity of cyclic RNA (Ribonucleic Acid) Circ9:135881633|135883078 from a brain tissue in preparing a prognostic preparation of a glioma patient. The study proves that patients with higherexpression quantity of the cyclic RNA Circ9:135881633|135883078 in the glioma have a higher postoperative survival rate. Prognostic judgement of the glioma patients is made by detecting the expressionlevel of the cyclic RNA Circ9:135881633|135883078 in glioma tissues of the glioma patients.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biotechnology and relates to the application of a brain tissue-derived circRNA marker for glioma prognosis, that is, the application of a reagent for detecting the marker in the preparation of a glioma prognosis preparation. Background technique

[0002] Glioma is the most frequent brain tumor in adults, accounting for 40.49% of intracranial tumors. From the time of diagnosis, the average life expectancy of patients with glioma is less than five years. In order to diagnose and treat glioma, a malignant disease highly correlated with genetic material, it is necessary to explore its pathogenesis at the level of molecular biology and from the expression of genetic information. At present, although the diagnosis and treatment methods of glioma are in the stage of continuous improvement, the survival rate of glioma patients has not improved significantly. The diagnosis of glioma is still in the empirical stage based o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More